Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. general practitioners and internists) are asked to document relevant data related to esomeprazole therapy in patients with gastrointestinal disorders. Patients with acid associated gastrointestinal symptoms can be included.
Study Type
OBSERVATIONAL
Enrollment
29,586
efficacy and tolerability of esomeprazole in patients who are treated by general practitioners and internists
Time frame: proportion of treated subjects without any specific acid associated symptoms at the end of the study; change in intensity of specific acid associated symptoms; incidence of the occurrence of unknown, unexpected and/or rarely occurring adverse events AE.
evaluation of a diagnosis tool
Time frame: evaluation of the predictive value of a two items questionnaire on acid associated symptoms
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.